Medical marijuana and the developing role of the pharmacist

American Journal of Health-System Pharmacy

Volumn 64, Issue 10, 2007, Pages 1037-1044

  Seamon, Matthew J ^a   Fass, Jennifer A ^a   Maniscalco Feichtl, Maria ^a   Abu Shraie, Nada A ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Cannabis; Drug interactions; Laws; Mechanism of action; Toxicity

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABIS; DEXTRO ASPARTIC ACID; DOPAMINE; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; TETRAHYDROCANNABINOL;

CARDIOVASCULAR DISEASE; DRUG INDICATION; DRUG LEGISLATION; GLAUCOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; MALIGNANT NEOPLASTIC DISEASE; MENTAL DISEASE; MULTIPLE SCLEROSIS; NAUSEA; NEUROLOGIC DISEASE; PAIN; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SMOKING; SPASTICITY; UNITED STATES; VOMITING; WEIGHT REDUCTION;

EID: 34249085356     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060471     Document Type: Review

References (70)

1. Seamon MJ. The legal status of medical marijuana. Ann Pharmacother. 2006; 40:2211-5.
2. Okie S. Medical marijuana and the Supreme Court. N Engl J Med. 2005; 353:648-51.
3. Jouvenal J. Fast-food giants outnumbered by pot clubs. San Francisco Exam. Jul 18, 2005.
4. Ben Amar M. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol. 2006; 105:1-25.
5. Hall W, Degenhardt L. Medical marijuana initiatives: are they justified? How successful are they likely to be? CNS Drugs. 2003; 17:689-97.
6. Joy JE, Watson SJ, Benson JA. Marijuana and medicine: assessing the science base. Washington, DC: National Academy Press; 1999.
7. Kumar RN, Chambers WA, Pertwee RG. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia. 2001; 56:1059-68.
8. National Institute on Drug Abuse. Research report series. Marijuana abuse. www.drugabuse.gov/PDF/RRMarijuana.pdf (accessed 2006 Oct 1).
9. Cesamet (nabilone) package insert. Costa Mesa, CA: Valeant Pharmaceuticals International; 2006 May.
10. Burns TL, Ineck JR. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. Ann Pharmacother. 2006; 40:251-60.
11. Ibrahim MM, Porreca F, Lai J et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci. 2005; 102:3093-8.
12. Baker D, Pryce G, Giovannoni G et al. The therapeutic potential of cannabis. Lancet Neurol. 2003; 2:291-8.
13. 21 U.S.C. 812.
14. Gonzales v. Raich, 545 U.S. 1 (2005).
15. National Institutes of Health. Workshop on medical utility of marijuana. www.nih.gov/news/medmarijuana/MedicalMarijuana.htm#EXECUTIVE (accessed 2006 Oct 1).
16. Freeman RM, Adekanmi O, Waterfield MR et al. The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS). Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17:636-41.
17. House of Lords. Science and technology, ninth report. www.publications.parliament.uk/pa/ld199798/ldselect/ldsctech/151/15101.htm (accessed 2006 Oct 1).
18. Carter GT, Rosen BS. Marijuana in the management of amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2001; 18:264-70.
19. Muller-Vahl KR, Schneider U, Prevedel H et al. Delta 9- tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry. 2003; 64:459-65.
20. Hollister LE. An approach to the medical marijuana controversy. Drug Alcohol Depend. 2000; 58(1-2):3-7.
21. Alger BE. Endocannabinoids and their implications for epilepsy. Epilepsy Curr. 2004; 4:169-73.
22. Russo E. Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain. 1998; 76(1-2):3-8.
23. Volfe Z, Dvilansky A, Nathan I. Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients. Int J Clin Pharmacol Res. 1985; 5:243-6.
24. Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001; 178:107-15.
25. Howard J, Anie KA, Holdcroft A et al. Cannabis use in sickle cell disease: a questionnaire study. Br J Haematol. 2005; 131:123-8.
26. Zhan GL, Camras CB, Palmberg PF et al. Effects of marijuana on aqueous humor dynamics in a glaucoma patient. J Glaucoma. 2005; 14:175-7.
27. Short B. Asthma in young Canadians and marihuana use. CMAJ. 1987; 137:1080. Letter.
28. Williams SJ, Hartley JP, Graham JD. Bronchodilator effect of delta 1-tetrahydrocannabinol administered by aerosol of asthmatic patients. Thorax. 1976; 31: 720-3.
29. Gong H Jr, Tashkin DP, Calvarese B. Comparison of bronchial effects of nabilone and terbutaline in healthy and asthmatic subjects. J Clin Pharmacology. 1983; 23:127-33.
30. Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. J Psychoactive Drugs. 1998; 30:171-7.
31. Gilson I, Busalacchi M. Marijuana for intractable hiccups. Lancet. 1998; 351:267. Letter.
32. Eidelman WS. Should physicians support the medical use of marijuana? Yes: it can be effective when all else fails. Point. West J Med. 2002; 176:76.
33. Kosior DA, Fillipiak KJ, Stolarz P et al. Paroxysmal atrial fibrillation in a young female patient following marijuana intoxication: a case report of possible association. Med Sci Monit. 2000; 6:386-9.
34. Mittleman MA, Lewis RA, Maclure M et al. Triggering myocardial infarction by marijuana. Circulation. 2001; 103:2805-9.
35. Lindsay AC, Foale RA, Warren O et al. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol. 2005; 104:230-2.
36. Mouzak A, Agathos P, Kerezoudi E et al. Transient ischemic attack in heavy cannabis smokers: how 'safe' is it? Eur Neurol. 2000; 44:42-4.
37. Moore BA, Augustson EM, Moser RP et al. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med. 2005; 20:33-7.
38. Zhang ZF, Morgenstern H, Spitz MR et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999; 8:1071-8.
39. Hashibe M, Straif K, Tashkin DP et al. Epidemiologic review of marijuana use and cancer risk. Alcohol. 2005; 35:265-75.
40. Cannabis. In: AltMedDex System. Thomson Micromedex. www.thomsonhc.com/ hcs/librarian (accessed 2006 Jun 30)
41. Cannabis. In: Martindale: the complete drug reference. Thomson Micromedex. www.thomsonhc.com/hcs/librarian (accessed 2006 Jun 30)
42. Gross DW, Hamm J, Ashworth NL et al. Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center. Neurology. 2004; 62:2095-7.
43. Bonkowsky JL, Sarco D, Pomeroy SL. Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure. Pediatr Emerg Care. 2005; 21:527-8.
44. Gordon E, Devinsky O. Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia. 2001; 42:1266-72.
45. Natural Medicines Comprehensive Database. Marijuana. www.naturaldatabase. com (accessed 2006 Jun 30).
46. Johns A. Psychiatric effects of cannabis. Br J Psychiatry. 2001; 178:116-22.
47. Laumon B, Gadegbeku B, Martin JL et al. Cannabis intoxication and fatal road crashes in France: population based case-control study. BMJ. 2005; 331:1371-4. [Erratum, BMJ. 2006; 332:1298.]
48. Liguori A, Gatto CP, Jarrett DB. Separate and combined effects of marijuana and alcohol on mood, equilibrium and simulated driving. Psychopharmacology. 2002; 163:399-405.
49. Robbe H. Marijuana's impairing effects on driving are moderate when taken alone but severe when combined with alcohol. Hum Psychopharmacol. 1998; 13(suppl 2):S70-8.
50. U.S. Department of Justice. Exposing the myth of medical marijuana. www.usdoj.gov/dea/ongoing/marijuanap.html (accessed 2006 Jul).
51. Ratey JJ, Ciraulo DA, Shader RI. Lithium and marijuana. J Clin Psychopharmacol. 1981; 1:32-3.
52. Symons IE. Cannabis smoking and anaesthesia. Anaesthesia. 2002; 57:1142-3. Letter.
53. Stoll AL, Cole JO, Lukas SE. A case of mania as a result of fluoxetine-marijuana interaction. J Clin Psychiatry. 1991; 52:280-1.
54. McLeod AL, McKenna CJ, Northridge DB. Myocardial infarction following the combined recreational use of Viagra and cannabis. Clin Cardiol. 2002; 25:133-4.
55. Mannion V. Case report: adverse effects of taking tricyclic antidepressants and smoking marijuana. Can Fam Physician. 1999; 45:2683-4.
56. Wilens TE, Biederman J, Spencer TJ. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry. 1997; 36:45-8.
57. Hillard JR, Vieweg WV. Marked sinus tachycardia resulting from the synergistic effects of marijuana and nortriptyline. Am J Psychiatry. 1983; 140:626-7.
58. Kizer DW. Possible interaction of TCA and marijuana. Ann Emerg Med. 1980; 9:444. Letter.
59. Rejon Altable C, Rodriguez Urrutia A, Carrion Martinez MI. Cannabis-induced extrapyramidalism in a patient on neuroleptic treatment. J Clin Psychopharmacol. 2005; 25:91-2. Letter.
60. Knudsen P, Vilmar T. Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatr Scand. 1984; 69:162-74.
61. Marks WH, Florence L, Lieberman J et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation. 1996; 61:1771-4.
62. Cabral GA, Staab A. Effects on the immune system. Handb Exp Pharmacol. 2005; 168:385-423.
63. Haney M, Rabkin J, Gunderson E et al. Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology. 2005; 181:170-8.
64. Smit F, Bolier L, Cuijpers P. Cannabis use and the risk of later schizophrenia: a review. Addiction. 2004; 99:425-30.
65. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry. 2001; 158:2033-7.
66. Mathew RJ, Wilson WH, Davis R. Postural syncope after marijuana: a transcranial Doppler study of the hemodynamics. Pharmacol Biochem Behav. 2003; 75:309-18.
67. Marijuana. In: Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in pregnancy and lactation. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
68. Trivers KF, Mertens AC, Ross JA et al. Parental marijuana use and risk of childhood acute myeloid leukaemia: a report from the Children's Cancer Group (United States and Canada). Paediatr Perinat Epidemiol. 2006; 20:110-8.
69. United States v. Oakland Cannabis Buyer's Cooperat, 532 U.S. 483 (2001).
70. California Highway Patrol. Update on medical marijuana enforcement policy. www.safeaccessnow.org/downloads/CHP_policy_update_memo.pdf (accessed 2005 Jul 6).